echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 2015 pharmaceutical industry event

    2015 pharmaceutical industry event

    • Last Update: 2015-12-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [editor's point of view of chinapharma.com] 2015 is coming to an end This year, everyone is surrounded by the words of medical treatment, drug price liberalization, Internet + and hierarchical diagnosis and treatment What's the major event in the whole pharmaceutical industry this year? What are we closely related to? Today, chinapharma.com will bring you 2015 pharmaceutical industry event at the end of the year to help you have a deeper understanding of 2015 pharmaceutical market 1 The National 863 plan anti-tumor major innovative drug "xidaaniline" has been approved to be listed globally as an original Chinese anticancer new drug xidaaniline It is a subtype selective histone deacetylase oral inhibitor approved to be listed globally, and an original new drug authorized by China to be used in the United States and other developed countries The listing of xidaaniline marks the significant improvement of the core technologies and capabilities in the whole process from structural based molecular design, target research, safety evaluation, clinical development to industrialization in China, which is a historic breakthrough in China's pharmaceutical industry 2 The Ministry of science and technology held an expert meeting on national medical strategy, and put forward the information from the national health and Family Planning Commission of China's medical plan that at present China is preparing a "medical" strategic plan, which may be included in the major scientific and technological projects of the 13th five year plan In March this year, the Ministry of science and technology held an expert meeting on national medical strategy and proposed China's medical plan The meeting pointed out that by 2030, China will invest 60 billion yuan in the field of medical care III The government officially liberalizes drug pricing The national development and Reform Commission, together with the national health and Family Planning Commission, the Ministry of human resources and social security and other departments jointly issued the notice on printing and distributing the opinions on promoting the reform of drug prices, and decided to cancel most of the government pricing of drugs from June 1, 2015, improve the drug procurement mechanism, and play the role of medical insurance and fee control The actual transaction price of drugs is mainly formed by market competition IV The State Council officially issued a document to support that "Internet medical care" will become the next outlet in July this year "The guidance for action was officially released The guidance proposed that we should vigorously develop the emerging consumption based on Internet and online and offline interaction, accelerate the development of emerging services such as medical, health, pension and social security based on the Internet, and encourage the pharmaceutical industry to use e-commerce platform to optimize the procurement and distribution system and improve the business efficiency of enterprises New Internet technology is leading us into a new era of medical revolution, especially in the field of emergency and telemedicine, which is convenient for more real-time transmission and sharing of data and medical resources, timely and accurate treatment Internet medical treatment has become an unstoppable trend V the guiding opinions of the general office of the State Council on promoting the construction of the hierarchical diagnosis and treatment system promulgated and issued by the general office of the State Council on promoting the construction of the hierarchical diagnosis and treatment system deployment to accelerate the construction of the hierarchical diagnosis and treatment system, form a scientific and orderly medical pattern, improve the people's health level, and further guarantee and improve people's livelihood It is also pointed out that by 2017, the hierarchical diagnosis and treatment policy system will be gradually improved, the division of labor and cooperation mechanism of medical and health institutions will be basically formed, the medical resources will sink orderly and effectively, the construction of grass-roots medical and health personnel team focusing on general practitioners will be strengthened, the utilization efficiency of medical resources and the overall benefit will be further improved, and the proportion of diagnosis and treatment volume of grass-roots medical and health institutions in the total diagnosis and treatment volume will be significantly increased, The medical order is more reasonable and standardized 6 Tu youyou won the Nobel Prize for physiology or medicine on October 8, 2015 Tu Youyou, a Chinese woman pharmacist, won the Nobel Prize for physiology or medicine in 2015 and became a Chinese who won the Nobel Prize for science of nature Tu youyou won the Nobel Prize, reflecting the prosperity and progress of science and technology in China, the great contribution of traditional Chinese medicine to human health, and the continuous improvement of China's comprehensive national strength and international influence 7 Mobile medical service: the article "on the fall of doctor Chunyu" caused the mobile medical market turbulence in October this year, the article "on the fall of doctor Chunyu" went crazy in the circle of friends, which caused many controversies about the mobile medical service with uncertain future A debate about the fate of mobile medical service was ignited Despite the so-called conspiracy theory, the rapid spread of the news shows how uncertain the market is about Internet health care Compared with any traditional industry that the Internet has entered, the disputes and fierce positions caused by the development of Internet Medical are rare With the development of Internet health care, the confidence of the whole market has been very deficient If the confidence of the market cannot be reversed in the short term, it is inevitable that the whole market will be shuffled With the coming of the cold winter of the macro market, how to deal with the difficulties together is the focus of mobile medical companies VIII The national health and Family Planning Commission launched the healthy China construction plan Since the new concept of "healthy China" was put forward in the communique of the Fifth Plenary Session of the 18th CPC Central Committee, the national health and Family Planning Commission has recently launched the preparation of the healthy China Construction Plan (2016-2020) in an all-round way and started to solicit opinions from the public The plan will become a programmatic document to promote the construction of healthy China in the next five years, and the relevant industries and companies in the field of medical health may have a good opportunity for rapid development 9 Pfizer's acquisition of Pfizer is close to reaching an agreement with Allergan at a price of up to $380 per share The total value of Elgin and Pfizer is more than 400 billion US dollars According to the purchase price proposed by Pfizer, the market value of the two companies is more than 340 billion US dollars The merger of the two companies will become one of the largest M & A cases in the history of medicine 10 The Pharmacopoeia of the people's Republic of China (2015 version) was officially implemented on December 1 The Pharmacopoeia of the people's Republic of China (2015 version) was officially implemented: 1082 new varieties were added to the new pharmacopoeia on the basis of the Pharmacopoeia of 2010 version, and the total number of varieties collected reached 5608 In order to ensure the safety of drug use, the requirements of safety control are increased and improved Mainly for sulfur dioxide, heavy metals, pesticide residues, ash and other excessive, as well as mycotoxins, pigments, harmful elements and other harmful substances, microorganisms and related pathogens control Under the strict supervision of the new pharmacopoeia, the development of the pharmaceutical industry will be more and more standardized.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.